About Stella Pharmaceuticals
Stella Pharmaceuticals is a Healthcare company. It operates as a wholesale trader and exporter of pharmaceutical medicines and injections. It operates on a B2B model. Its Indian entity Stella Pharmaceuticals Private Limited reported revenue of ₹68.6 Lakh. Stella Pharmaceuticals offers products and services including General Medicines, Anti-Cancer Medicines, Injectables, Cardiovascular Medicines, and Skin Care Products. Its focus areas include Pharmaceuticals, Medicines, General Medicines and Oncology. Its competitors include AmerisourceBergen, Entero Healthcare, Target Healthcare, CHEPLAPHARM and EBOS Group and 5 more; 5 of its 10 listed competitors have raised funding.
Company details
Stella Pharmaceuticals Private Limited operates as a wholesale trader and exporter of various pharmaceutical drugs, including general medicines, anti-cancer treatments, and injectables. Incorporated in 2010 and based in Nagpur, Maharashtra, India, the company distributes products like tablets and capsules to businesses. It focuses on supplying high-quality pharmaceuticals through wholesale channels, serving distributors and healthcare providers in the market.
- SectorsHealthcare
- Phone•••• ••••
- Website stellapharmaceuticals.com
- Legal Name Stella Pharmaceuticals Private Limited
- Date of Incorporation 19 Jun, 2010
- Jurisdiction Nagpur, Maharashtra, India
- Annual Revenue₹68.6 Lakh
FY 2025 · +131% YoY
- Net Profit₹3.7 Lakh
FY 2025 · 5% margin
- EBITDA₹4.5 Lakh
FY 2025 · 7% margin
Associated legal entities of Stella Pharmaceuticals
Stella Pharmaceuticals operates through Stella Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stella Pharmaceuticals Private Limited CIN U51909MH2010PTC204482 | Active | 19 Jun 2010 | Nagpur, Maharashtra | ₹0.7 Cr | – | 3 | View details |
Products & Services of Stella Pharmaceuticals
Stella Pharmaceuticals offers a comprehensive portfolio of products and services, including General Medicines, Anti-Cancer Medicines, Injectables, Cardiovascular Medicines, and Skin Care Products.
Wholesale trading of various general medicines like tablets and capsules.
Trading of anti-cancer drugs such as Lapatinib tablets.
Supply of injectable drugs like Testenate Depot.
Wholesale of heart-related medicines like Sclerogem capsules.
Trading of skin treatments such as Isozip capsules.
Board of directors of Stella Pharmaceuticals Private Limited (Stella Pharmaceuticals)
Stella Pharmaceuticals Private Limited is the primary company behind Stella Pharmaceuticals. The board of Stella Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Murlidhar Radhakisan Kewalramani, appointed in 2010. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Murlidhar Radhakisan Kewalramani DIN 03076885 | Director | 19 Jun 2010 | 16 yrs 4 mo | Stella Pharmaceuticals Private Limited |
| Amir Asghar Ali DIN 03075921 | Director | 19 Jun 2010 | 16 yrs 4 mo | Stella Pharmaceuticals Private Limited |
| Sushil Murildhar Kewalramani DIN 06846240 | Director | 05 Feb 2024 | 2 yrs 8 mo | Stella Pharmaceuticals Private Limited |
Financials of Stella Pharmaceuticals
Figures of Stella Pharmaceuticals Private Limited, the primary company behind Stella Pharmaceuticals, for FY 2025. Revenue was ₹68.6 Lakh (+131% year on year). Net profit was ₹3.7 Lakh (5% margin). EBITDA was ₹4.5 Lakh (7% margin). Revenue has grown at a compounded annual rate of +209% over three years and -2% over five years.
- ₹68.6 LakhRevenue · FY 2025 · +131% YoY
- ₹3.7 LakhNet profit · 5% margin
- ₹4.5 LakhEBITDA · 7% margin
- ₹16.5 LakhPaid-up capital
- +209%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Stella Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Stella Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Stella Pharmaceuticals
Stella Pharmaceuticals has 10 listed competitors in our database, 5 of them funded. They include AmerisourceBergen, Entero Healthcare, Target Healthcare, CHEPLAPHARM and EBOS Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| target-healthcare.co.uk | 2012 | East Kilbride, United Kingdom | $26.15M | 45 | Distributor of pharmaceutical products | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| ebosgroup.com | 1922 | Docklands, Australia | – | – | Wholesaler & distributor of healthcare, medical, and pharmaceutical products | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| renee.com | 2021 | Los Angeles, United States | $8.2M | – | Diversified drugs are distributed by Renee in the United States. | |
| neuca.pl | 1990 | Torun, Poland | – | – | Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | |
| oriola.com | 1997 | Espoo, Finland | – | – | Pharmaceutical drugs and supplements are distributed by Oriola in Finland. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed competitors of Stella Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Stella Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stella Pharmaceuticals
The primary company behind Stella Pharmaceuticals, Stella Pharmaceuticals Private Limited, reported revenue of ₹68.6 Lakh for FY 2025, up 131% year on year.
Stella Pharmaceuticals Private Limited operates as a wholesale trader and exporter of various pharmaceutical drugs, including general medicines, anti-cancer treatments, and injectables. Incorporated in 2010 and based in Nagpur, Maharashtra, India, the company distributes products like tablets and capsules to businesses. It focuses on supplying high-quality pharmaceuticals through wholesale channels, serving distributors and healthcare providers in the market.
Stella Pharmaceuticals's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Stella Pharmaceuticals offers General Medicines, Anti-Cancer Medicines, Injectables, Cardiovascular Medicines, and Skin Care Products.
Stella Pharmaceuticals operates through Stella Pharmaceuticals Private Limited.
The legal entities of Stella Pharmaceuticals currently have 3 directors, including Murlidhar Radhakisan Kewalramani, Amir Asghar Ali, Sushil Murildhar Kewalramani.